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Mycobacterium tuberculosis (Mtb) is a facultative intra-
cellular microbial pathogen with a strong propensity
for invading the macrophages. Subversion of the macro-
phage immune functions or activation response fol-
lowing its infection with Mtb constitutes the hallmark
of mycobacterial pathogenesis [1]. Successful parasiti-
zation of macrophages by pathogenic mycobacteria
involves modulation of several host cell processes such
as surface expression of costimulatory and major histo-
compatibility molecules [2–5], antigen processing and
presentation, maturation of mycobacterial phagosome
[6–9], etc., accompanied with underlying nuances in
the host cell signaling, which allow Mtb to survive
inside the host cells [10]. A 19-kDa lipoprotein of Mtb
and a cell-wall component, lipoarabinomannan
(LAM), have been implicated in modulation of macro-
phage functions [11–13]. However, a possible role of
Mtb secretory proteins in the modulation of macro-
phage functions remains to be investigated in detail.
We have been studying immunomodulatory role of a
10-kDa, Mtb secretory antigen (MTSA-10 [14]). In
Mtb, MTSA-10 and a 6-kDa early secretory antigen
target (ESAT-6) are cotranscribed from Rv3874 and
Rv3875 genes, respectively [15], located in the so-called
‘region of difference 1’ (RD1) locus of the Mtb
genome [16]. The possible role of the RD1 locus in
mycobacterial virulence first became apparent from the
comparative genomics studies indicating lack of RD1
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Macrophages are the primary host cells for Mycobacterium tuberculosis
(Mtb). Although macrophages can mount a strong inflammatory response
to dispose of invading microbial pathogens, the immune dysfunction of the
Mtb-infected macrophage constitutes the hallmark of mycobacterial patho-
genesis. A 10-kDa, Mtb secretory antigen (MTSA-10), encoded by ORF
Rv3874, is one of the predominant members of the ‘region of difference 1’
locus of Mtb genome that has been strongly implicated in mycobacterial
virulence. In this study, we investigated the possible role of MTSA-10 in
modulating the macrophage dysfunction in a mouse macrophage cell line
J774.1. We found that recombinant MTSA-10 caused extensive protein
dephosphorylation in J774.1 cells as revealed by two-dimensional gel elec-
trophoresis analysis. We also observed that MTSA-10 treatment downregu-
lated the reactive oxygen species levels in the cells leading to activation of
cellular protein phosphatases putatively responsible for the dephosphoryla-
tion phenomenon. This implied a direct role of MTSA-10 in the disruption
of host cell signaling, resulting in downregulation of transcription of sev-
eral genes essential for macrophage function.
Abbreviations
DPI, diphenylene iodonium; ESAT-6, 6-kDa early secretory antigen target; IFN, interferon; IPG, immobilized pH gradient; LAM,
lipoarabinomannan; LPS, lipopolysaccharide; Mtb, Mycobacterium tuberculosis; MBP, myelin basic protein; MTSA-10, M. tuberculosis
secretory antigen; NAC, N-acetylcysteine; pNPP, para-nitrophenyl phosphate; PTP, protein tyrosine phosphatase; RD1, region of difference 1;
ROS, reactive oxygen species.
FEBS Journal 273 (2006) 5517–5534 ª 2006 The Authors Journal compilation ª 2006 FEBS 5517
in all BCG vaccine strains of Mycobacterium bovis
[17–19]; several subsequent studies on biogenesis, secre-
tion and immunogenicity of RD1 proteins have
directly implicated this locus in mycobacterial patho-
genesis and virulence in mice [20–23]. Significantly,
targeted deletion of RD1 from Mtb attenuates its viru-
lence in mice [24]; conversely, incorporation of RD1
locus of Mtb into BCG or Mycobacterium microti, a
natural RD1 deletion mutant, imparts them with
enhanced virulence and immunogenicity [21,25]. Muta-
tions in RD1 secretion pathway subverted secretion of
ESAT-6 and MTSA-10 and resulted in reduced Mtb
replication in cultured macrophages, as the mutants
failed to inhibit the macrophage inflammatory
responses [22].
We have earlier shown that MTSA-10 can bind to
the macrophage surface [26]; subsequently, Renshaw
et al. [27] have demonstrated that the long flexible arm
formed by the C-terminus of MTSA-10 was essential
for binding of the MTSA-10:ESAT-6 complex to the
cell surface. In the present study, we have examined
some aspects of regulation of the host cell signaling by
MTSA-10. Here, we demonstrate that MTSA-10 cau-
ses extensive dephosphorylation of the macrophage
proteins; interestingly, this is accompanied by the
downregulation of reactive oxygen species (ROS) gen-
eration in the macrophages treated with MTSA-10
leading to enhanced activity of cellular phosphatases
and consequent dampening of the macrophage basal
signaling machinery.
Results
MTSA-10 causes global dephosphorylation
of macrophage phosphoproteome
We have previously shown that MTSA-10 could modu-
late the macrophage immune functions, possibly by
interfering with the signaling machinery of the host cell
[14,26]. As phosphorylation and dephosphorylation
constitute the key events in cell signaling, we decided to
ascertain the role of MTSA-10 in these events. In order
to establish the possible involvement of MTSA-10 in the
phosphorylation events, J774.1 cells, pre-equilibrated
with [32P]-orthophosphoric acid as described in the
Experimental procedures section, were exposed to
experimentally predetermined optimal dose of purified,
lipopolysaccharide (LPS)-free, recombinant MTSA-10
protein. The cell lysates prepared at different time
points of incubation were resolved by two-dimensional
gel electrophoresis and analyzed by autoradiography.
Results obtained from one such experiment are
shown in Fig. 1. Treatment of cells with MTSA-10
resulted in a decrease in the number of detectable
phosphoproteins (Fig. 1A, right panel) as compared
with those detected in the untreated cells (Fig. 1A, left
panel). After normalizing the two autoradiograms for
background intensity and analyzing them using the
image master 2d elite software (Amersham Bio-
science), we could detect 62 spots, each representing a
phosphorylated protein, in the untreated cells, and
only 37 in the MTSA-10-treated cells. Seventeen spots
appeared to be common in the two panels, while 20
additional spots in the right panel represented de novo
phosphorylated proteins as a result of MTSA-10 treat-
ment. However, in the presence of MTSA-10, there
was an overall decrease in the number of detectable
phosphoproteins; this effect was maximal at 20 min
after the addition of MTSA-10, and persisted with vir-
tually no change for up to 1 h (data not shown). Inter-
estingly, MTSA-10 treatment resulted in significant
dephosphorylation of 58 out of 62 spots seen in the
untreated cells. In fact, phosphorylation was undetect-
able in 45 of the normally phosphorylated proteins.
Data in Fig. 1B,C suggest that MTSA-10 could be
exerting substantial signal dampening effect on macro-
phage signaling machinery as the cells stimulated with
MTSA-10 could not maintain the basal phosphoryla-
tion status of cellular proteins both in qualitative and
quantitative terms. While a large number of proteins
failed to maintain their phosphorylated state after
MTSA-10 treatment, even the few that could suffered
a significant loss in the level of phosphorylation as
compared with that observed in the untreated cells.
Supplementary Fig. S1 diagrammatically represents
the intensity profile of the individual phosphoprotein
spots. It depicts significant reduction in the magnitude
of phosphorylation of most proteins following treat-
ment with MTSA-10 (e.g. spots 6, 29, 30, 31, 35 and
53). It also shows that the magnitude of phosphoryla-
tion of the new substrates was rather low (e.g. spots
64, 65, 66, 67, 68 and 70), indicating that only a very
small pool of these proteins was being phosphorylated.
Most importantly, these results indicate that the effect
of MTSA-10 was not restricted to any specific subset
of target proteins; rather it seemed to be a global phe-
nomenon in which a significant proportion of macro-
phage proteins were affected.
MTSA-10 treatment regulates macrophage
phosphatase activity
The dephosphorylation of macrophage proteins caused
by MTSA-10 seemed rather intriguing, especially as we
found no evidence of any intrinsic phosphatase activity
in MTSA-10. Others have shown that some Mtb
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products like LAM can activate macrophage protein
tyrosine phosphatases (PTPs) [12] while, conversely,
bacterial lipopolysaccharide is known to inactivate
phosphatases. Therefore, we decided to ascertain if
MTSA-10 could activate phosphatases and thereby
influence the cellular phosphorylation events in the
macrophage.
To measure the cellular phosphatase activity upon
MTSA-10 treatment, we used a para-nitrophenyl phos-
phate (pNPP) hydrolysis assay for measuring the tyro-
sine phosphatases, and a phosphopeptide as substrate
to measure the serine ⁄ threonine phosphatases, as men-
tioned in the Experimental procedures. It is perhaps
pertinent to point out here that pNPP, an artificial
protein tyrosine phosphatase (PTP) substrate [28], is
not as specific for tyrosine phosphatases as, for exam-
ple, the 1142–1153 residue insulin receptor peptide
[29]; however, as a number of studies have used pNPP
for measuring activity of PTPs [30–33], and pNPP has
been shown to serve well as a substrate for comparing
activities of a newly characterized tyrosine phosphatase
HopPtoD2 from Pseudomonas syringae and the human
lymphocyte antigen-related protein (CD45), a known
PTP [34], we have ventured to use pNPP assay as the
routine assay for measuring tyrosine phosphatase
activity in the present study. We observed that the
overall level of phosphatase activity in the cytoplasmic
extracts, as measured in a pNPP assay, did not
increase significantly during the first 5 min of MTSA-
10 treatment, but registered 60% increase by 10 min;
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Fig. 1. MTSA-10 dampens macrophage signaling machinery. (A) The autoradiograms obtained upon two-dimensional gel electrophoresis
resolution of the phosphorylated proteins from untreated cells and cells treated with MTSA-10 for 20 min. For clarity, only autoradiograms
from the region spanning molecular mass range of 10–75 kDa and pI range of 4–7 are shown. The arrowheads indicate some representative
spots dephosphorylated by MTSA-10 treatment, while some of those that were phosphorylated by MTSA-10 are enclosed in circles. Spots
that remained unchanged by the treatment and are used as internal reference standards for analysis are enclosed in rectangle. (B) Diagram-
matic representation of the number of phosphorylation events detected in untreated and MTSA-10 treated cells. (C) Percentage of phos-
phorylation and dephosphorylation events in MTSA-10-treated cells as compared with untreated cells. All values in (B) and (C) represent the
mean of three different experiments.
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half of this activity could be detected even after
30 min of treatment (Fig. 2A). Interestingly, the
serine ⁄ threonine phosphatases showed a gradual
increase in their enzymatic activity and were found to
be 150% more active after 30 min of MTSA-10 treat-
ment as compared with the untreated cells (Fig. 2B).
To study the effect of MTSA-10 on cellular phos-
phatases in further detail, we selected a subset of nine
cellular phosphatases encompassing tyrosine (SHP-1,
SHP-2, HePTP and PTP1B), dual specificity (MKP-1
and MKP-2) and serine ⁄ threonine phosphatases (PP1,
PP2A and PP2B) and monitored their activity upon
MTSA-10 treatment. The individual phosphatases were
immunoprecipitated from cytoplasmic extracts of
MTSA-10-treated cells and were assayed for their
activity. The results of one such experiment are shown
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Fig. 2. MTSA-10 activates macrophage phosphatases. Cells (2 · 107 ⁄ aliquot) were treated with MTSA-10 for indicated time. (A) Cytoplasmic
fractions were subjected to an assay for detecting tyrosine phosphatase activity. (B) Cytoplasmic fractions were subjected to an assay for
detecting serine ⁄ threonine phosphatase activity. (C) Individual phosphatases were pulled down by immunoprecipitation and the immunopre-
cipitates were subjected to respective phosphatase assay as described in Experimental procedures. In all cases, the activity was shown as
percent increase with respect to that obtained in the untreated control cells. In all assays where specific phosphatases were immunoprecipi-
tated, equal protein amounts across various time points were ascertained by western blotting of immunoprecipitates. Data presented in (A)
and (B) are the mean ± SD of three separate experiments.
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in Fig. 2C. We found that the tyrosine and dual specif-
icity phosphatases reached maximum level of their
activity by 10–15 min of treatment; however, by
30 min of MTSA-10 treatment, activity of HePTP
decreased to nearly basal level, while others, namely
SHP-2, PTP1B, MKP-1 and 2 still remained partially
active. A paradox was seen in the case of SHP-1, as its
activity moderately decreased upon MTSA-10 treat-
ment. The reason for this decreased activity of SHP-1
is not clear to us as yet.
All the serine ⁄ threonine phosphatases, however,
showed a gradual increase in their activity with treat-
ment time and were still active at 30 min of MTSA-10
treatment. The kinetics of activation and the level
of maximum activity achieved were found to vary
between the individual phosphatases (Fig. 2C). The
immunoprecipitates obtained with nonspecific antibod-
ies showed negligible phosphatase activity as compared
with the untreated cells (data not shown).
The overall message from these experiments was that
MTSA-10 upregulated both the tyrosine and ser-
ine ⁄ threonine phosphatases of macrophage cells, albeit
with different kinetics. The overall increase in activity
of the cellular phosphatases seemed to be responsible
for the global dephosphorylation observed in the cells
treated with MTSA-10.
MTSA-10 regulates ROS generation in the
macrophage
Phagocytes such as macrophages and neutrophils are
specially endowed to produce ROS through activation
of NADPH oxidase [35]. Release of ROS, also called
‘the respiratory burst’, not only helps in killing the
pathogen, but also plays an important role in the host
cell signaling [36,37]. ROS such as superoxide and
hydrogen peroxide (H2O2) have been implicated as sec-
ond messenger molecules in diverse receptor-mediated
signal transduction systems, such as epidermal growth
factor, platelet derived growth factor, insulin, B cell
receptor and T cell receptor [38–40].
Therefore, we next probed the effect of MTSA-10 on
ROS generation by J774.1 cells that had been preloaded
with an ROS sensitive dye, dichlorodihydrofluorescein
diacetate (H2DCFDA). We found that MTSA-10 could
significantly impair the production of ROS by J774.1
cells in a time-dependent manner (Fig. 3A,B), and this
inhibition was directly proportional to the concentration
of MTSA-10 used (Fig. 3C). As expected, ROS gene-
ration by J774.1 cells was markedly inhibited by addi-
tion of a NADPH oxidase inhibitor, diphenylene
iodonium (DPI), the glutathione peroxidase mimetic,
ebselen, and the antioxidant, N-acetylcysteine (NAC). It
is worthwhile mentioning that MTSA-10 seemed to
enhance the effect of all three inhibitors resulting in
further downregulation of ROS generation (Fig. 3D).
Moreover, as shown in Fig. 3E, we found that the
inhibition of ROS generation seemed to be MTSA-10-
specific; several other proteins such as chicken egg
lysozyme, Mtb secretory antigens Ag85B and ESAT-6,
and a Plasmodium falciparum merozoite surface protein
MSP119 had virtually no effect on ROS generation by
J774.1 cells (Fig. 3E).
The fact that MTSA-10 binds to macrophage cell
surface [26,27] and our finding that MTSA-10 inhib-
ited the macrophage ROS generation made us wonder
if the effect on ROS generation was a result of either
MTSA-10 binding to specific cell surface receptor or a
physical interaction of MTSA-10 with any key player
of ROS metabolism within the cell. To answer this
question we checked ROS levels in J774.1 cells that
had been stably transfected with MTSA-10 gene, and
constitutively produced MTSA-10 protein within the
cells [41]. We found no difference in ROS levels of
untransfected (naı¨ve) and MTSA-10-transfected J774.1
cells, as well as trypsin-treated J774.1 cells (Fig. 4A).
Interestingly, treatment with MTSA-10 induced a com-
parable degree of inhibition of ROS in both naı¨ve and
MTSA-10-transduced J774.1 cells (Fig. 4B,C). It is
also worth mentioning that MTSA-10 had no effect on
ROS levels of the trypsin-treated J774.1 cells (Fig. 4D).
These data indicated that the macrophage ROS levels
were affected by specific binding of MTSA-10 to the
cell surface. Significantly, cleavage of the cell surface
receptors by trypsin treatment prevented MTSA-10
binding and abrogated its effect on ROS levels. Fur-
thermore, the presence of MTSA-10 constitutively
expressed within the cell also had no effect on ROS
levels as evident from the comparable ROS levels in
naı¨ve and MTSA-10 transfected J774.1 cells. When
monitored over time, the effect of MTSA-10 treatment
on macrophage ROS levels prevailed at least up to 1 h
of treatment (Fig. S2A–F); monitoring for longer per-
iod revealed no shift in the ROS levels (Fig. S2A–F).
MTSA-10 has been reported to exist predominantly
as MTSA-10–ESAT-6 (1 : 1) complex, with the C-ter-
minal flexible arm of MTSA-10 being essential for
binding of the complex to the macrophage cell surface
[27]. Therefore, it seemed worthwhile to check the spe-
cificity of the effect of MTSA-10 on macrophage ROS
generation. We found that ESAT-6, the other counter-
part of the complex, had no effect on ROS generation
in J774.1 cells (Fig. S3A,B). Interestingly, the J774.1
cells treated with equimolar mixture of ESAT-6 and
MTSA-10 exhibited a reduction in the ROS levels
which was similar to that obtained with MTSA-10
S. K. Basu et al. Modulation of macrophage function by MTSA-10
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Fig. 3. Effect of MTSA-10 on macrophage ROS generation. (A–E) Profiles of generation of ROS, as measured by H2DCFDA oxidation are
shown. Briefly, H2DCFDA-labeled J774.1 cells were plated at 1 · 106 ⁄ 100 lL in wells of a 96-well plate, and the fluorescence signal
obtained under various conditions was recorded. (A) Results for untreated cells (d) and cells treated with MTSA-10 (s) for indicated time
are shown. The arrow indicates the time of addition of MTSA-10. (B) The FACS profile of ROS generation of untreated (——), and cells trea-
ted with MTSA-10 for 5 min (– Æ–) and 10 min (-----) are shown; the cells were preloaded with H2DCFDA and were subsequently subjected
to flowcytometric analysis. (C) The ROS generated by cells treated with different concentrations of MTSA-10 for 10 min are shown. Panel
(D) shows relative levels of ROS generation by un-treated cells (without any inhibitor; group 1), and cells treated with MTSA-10 alone
(group 2); cells treated with 7.5 lM DPI (group 3), or DPI plus MTSA-10 (group 4); with 50 lM ebselen (group 5) or ebselen plus MTSA-10
(group 6); with 50 mM NAC (group 7) or NAC plus MTSA-10 (group 8). (E) Relative levels of ROS generated by untreated cells (group 1), and
cells treated with MTSA-10 (group 2), or 10 lgÆmL)1 each of lysozyme (group 3), MSP119 (group 4), ESAT-6 (group 5) and Ag85-B (group 6)
are shown. In (E), the values are the mean ± SD of three different experiments.
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alone (Fig. S3C), or with the MTSA-10–ESAT-6
(1 : 1) complex (Fig. S3D) prepared according to Ren-
shaw et al. [38]. These results suggest that MTSA-10
alone had similar effect on the macrophage ROS gen-
eration as the MTSA-10–ESAT-6 (1 : 1) complex, and
therefore MTSA-10 in the complex was per se respon-
sible for this effect.
Furthermore, we obtained similar inhibitory effect
of MTSA-10 on ROS generation in another murine
macrophage cell line, RAW 264.7, as well (Fig. S4A).
Since nitric oxide scavenger, l-N-monomethyl arginine
had no effect on MTSA-10-dependent ROS inhibition
(Fig. S4B), MTSA-10 seemed to directly affect macro-
phage ROS generation or its half-life, and not the
feeder pathway via nitric oxide.
Also, we validated the inhibitory effect of MTSA-10
in the primary macrophage cultures. As shown in
Fig. S5, treatment of mouse peritoneal macrophages
with MTSA-10 led to reduction in ROS levels, while
ESAT-6 treatment had no detectable effect. In line with
our previous observation, in the peritoneal macrophages
treated with a physical mixture of MTSA-10 and ESAT-
6, as well as in those treated with MTSA-10–ESAT-6
(1 : 1) complex, we observed a reduction in the ROS
levels as compared with the untreated cells. This indi-
cates that the effect of MTSA-10 over ROS level is a
general phenomenon observed in macrophages.
MTSA-10 regulates macrophage phosphatase
activity in a ROS-dependent manner
Redox-regulatory mechanisms have been implicated in
activation of several receptor tyrosine kinases, basically
via inactivation of receptor associated phosphatases
[42]. Conversely downregulation of ROS generation
could allow PTPs to stay enzymatically active and
thereby prevent phosphorylation by protein tyrosine
kinases. The ROS oxidize the redox-regulated cysteine
in the catalytic site of the tyrosine phosphatase, render-
ing the latter inactive [38,43], while inactivation of the
Ser ⁄Thr phosphatase results from oxidation of a redox
sensitive binuclear metal ion centre in their catalytic
site, as documented in the case of calcineurin [44,45].
To establish whether any correlation existed between
the decreased level of ROS and an elevated degree of
phosphatase activity in MTSA-10 treated cells, we
immunoprecipitated each of the nine phosphatases
selected earlier (viz., HePTP, SHP-2, SHP-1, PTP-1B,
MKP-1, MKP-2, PP-1, PP-2A, and PP-2B) and studied
their activity under different treatment conditions.
In Fig. 5A, we present the results of an experiment
in which immunoprecipitates from untreated control
cells (group 1) and those treated as indicated (groups
2–7) were assayed for phosphatase activity. Treatment
of immunoprecipitates with a reducing agent, dithio-
threitol (group 2) resulted in a marked increase in the
enzyme activity of all nine phosphatases as compared
with the untreated controls. This result indicated that
in the macrophage, the basal level of phosphatases was
maintained by their oxidation, so that their treatment
with dithiothreitol, leading to reduction of the catalytic
site cysteine, led to an increase in their phosphatase
activity. A similar albeit less pronounced result was
obtained with NAC (50 mm) treatment (group 3),
although the magnitude of increase in the enzyme
activity varied for different phosphatases. Immunopre-
cipitates of cells treated with MTSA-10 for 10 min
(group 4) displayed a similar trend of increase in
Fig. 4. Reduction of macrophage ROS
generation needs binding of MTSA-10 on cell
surface. (A–D) The FACS profiles of ROS gen-
eration as measured by H2DCFDA oxidation
are shown. The profiles shown in (A) repre-
sent ROS levels seen in untreated,
untransfected J774.1 cells (——), MTSA-10-
transfected cells (ÆÆÆÆÆÆÆ), and the trypsin-trea-
ted, untransfected cells (----) [(ÆÆÆÆÆÆÆ) is masked
by (-----)]. (B) shows the FACS profiles of
ROS in untransfected, untreated J774.1 cells
(——) and in the cells treated with MTSA-10
for 10 min (-----). (C) shows profiles of ROS
in MTSA-10-transfected but untreated cells
(——) and MTSA-10 treated cells (-----). (D)
shows profiles of ROS in untransfected tryp-
sin-treated J774.1 cells (——) and trypsin
plus MTSA-10 treated cells (-----). Data pre-
sented is from one of three different experi-
ments with reproducible results.
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activity of all but one (SHP-1) phosphatases, which
was reversed by supplementation with H2O2 (group 5)
or enhanced by priming with NAC (group 6). Consis-
tent with the activity profile shown in Fig. 2C, the
tyrosine phosphatase SHP-1 displayed decreased activ-
ity upon MTSA-10 treatment. These results demon-
strate that the activity of phosphatases from the cells
could be independently enhanced either by treatment
with a reducing agent or by bringing down the level of
oxidant species in the cell. This experiment also tends
to suggest that MTSA-10 (group 4) helped increase the
cellular phosphatase activity by reducing the level of
ROS in the cell as its effect could be reversed by sup-
plementation with an oxidant species in the form of
H2O2 (group 5). A careful analysis of the results pre-
sented in Fig. 5A, however, reveals subtle variation in
the level of activation of oxidized PTPs as an effect of
MTSA-10; thus, MTSA-10 did not seem to signifi-
cantly affect phosphatase activity of MKP-1 and 2 in
the NAC-pretreated cells (group 3 versus 6), while in
the case of HePTP, SHP-2 or PTP-1B, we found that
MTSA-10 further enhanced their phosphatase activity
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Fig. 5. Reduction of ROS by MTSA-10 is
the cause for the activation of macrophage
phosphatase. (A) shows relative activity of
individual phosphatases immunoprecipitated
from untreated cells (group 1), immunopre-
cipitate treated with 1 mM dithiothreitol prior
to the phosphatase assay (group 2) and
from cells pretreated with 50 mM NAC
(group 3). The immunoprecipitation was car-
ried out from cells treated with MTSA-10 for
10 min (groups 4, 5 and 6) where the cells
were supplemented with H2O2 (group 5) or
pretreated with 50 mM NAC (group 6).
Group 7 shows the phosphatase activity of
the immunoprecipitates obtained with non-
specific antibodies. In all cases, the activity
shown represents the percent increase with
respect to the untreated control cells. (B)
and (C) show western blots of the total cel-
lular proteins from untreated cells (lane 1)
and cells treated with MTSA-10 for 20 min
(lanes 2, 3 and 4); additionally, cells were
supplemented with H2O2 (lane 3), or treated
with sodium orthovanadate (lane 4 in B) or
okadaic acid (lane 4 in C). Proteins were
fractionated by SDS ⁄ PAGE and probed with
anti-phosphotyrosine (B) or anti-phospho-
serine ⁄ threonine sera (C).
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in the NAC-pretreated cells (groups 3 versus 6), indica-
ting alternative ways of regulation of these (MKP1
and MKP2) phosphatases.
Results presented in Fig. 5B,C provide evidence for
a possible correlation between increase in phosphatase
activity due to reduction in ROS levels and global
dephosphorylation caused by MTSA-10 treatment.
Treatment of cells with MTSA-10 reduced the overall
protein tyrosine phosphorylation level (Fig. 5B, lane
2), as compared with untreated cells (Fig. 5B, lane 1);
this effect could be reversed independently either by
supplementation of ROS in form of H2O2 (Fig. 5B,
lane 3), or by preinactivation of cellular tyrosine phos-
phatases by sodium orthovanadate prior to MTSA-10
treatment (Fig. 5B, lane 4). Similarly, the reduced lev-
els of the serine ⁄ threonine phosphorylation in MTSA-
10-treated cells (Fig. 5C, lane 2), as compared with
untreated cells (Fig. 5C, lane 1), can also be reverted
back either by H2O2 treatment (Fig. 5C, lane 3) or by
inactivation of serine ⁄ threonine phosphatases by oka-
daic acid prior to MTSA-10 treatment (Fig. 5C, lane 4).
Together these results show that the dephosphoryla-
tion observed with MTSA-10 treatment was indeed
due to the reduction in ROS levels caused by MTSA-
10 treatment leading to higher levels of cellular phos-
phatases and consequent dephosphorylation of the
cellular proteins.
MTSA-10 regulates macrophage downstream
signaling and gene expression in a
ROS-dependent manner
A key strategy used by pathogens to survive in a hos-
tile environment is to interfere with normal cell signa-
ling in order to disable the host cell defenses. Different
bacterial pathogens use diverse strategies to achieve a
common goal of undermining host-cell functions and
thereby establishing a permissive niche for themselves
[46,47]. Mtb, being one of the most successful patho-
gens, employs more than one strategy for its own bene-
fit by differential regulation of host cell signaling [10].
Mitogen-activated protein kinase (MAPK) signaling
pathway is one of the most important cellular targets
of Mtb. While pro-inflammatory cytokine interferon
(IFN)-c induces activation of ERK1 ⁄ 2 at the distal
end of MAP kinase pathway leading to induction of
NOS-2 gene expression [48], LAM of Mtb is known to
limit ERK1 ⁄ 2 phosphorylation in THP-1 cells [12].
Nonpathogenic mycobacteria generally induce sus-
tained activation of MAP kinase in infected macro-
phages while virulent Mycobacterium avium induces a
rapid loss of the MAP kinase activity [49].
In view of our observations indicating dephosphory-
lating activity of MTSA-10, it seemed plausible to
explore whether MTSA-10 was affecting specific macro-
phage signaling pathways. So, we next investigated the
intracellular signaling events putatively affected by
MTSA-10, taking ERK1 ⁄ 2 as a model indicator mole-
cule for the downstream signaling along the MAPK
pathway, a favorite target of pathogenic mycobacteria
[12,49]. We found that MTSA-10 induced rapid de-
phosphorylation of ERK1 ⁄ 2 in the cytoplasm, as phos-
pho-ERK1 ⁄ 2 became virtually undetectable by 30 min
of MTSA-10 treatment. This effect was limited to dep-
hosphorylation only, as equivalent amount of ERK1 ⁄ 2
was detected through the entire time course of the
experiment (Fig. 6A). Interestingly, exogenous supply
of ROS in the form of H2O2 could effectively prevent
MTSA-10 from dephosphorylating ERK1 ⁄ 2 (Fig. 6A),
indicating that dephosphorylation could, indeed, be a
result of MTSA-10-dependent ROS inhibition. Fur-
thermore, addition of a PTP inhibitor, sodium ortho-
vanadate, restored the phosphorylation state of
ERK1 ⁄ 2 (Fig. 6A), corroborating that dephosphoryla-
tion of ERK1 ⁄ 2 was being mediated through MTSA-
10 induced protein phosphatases activation. In mouse
peritoneal macrophages as well, MTSA-10 induced
dephosphorylation of ERK in the cytoplasm without
affecting the ERK protein levels (Fig. S5E).
Next, we studied the effect of MTSA-10 on the kin-
ase activity of ERK1 ⁄ 2 (Fig. 6B–D). For this study,
ERK1 ⁄ 2 was immunoprecipitated from MTSA-10-trea-
ted cells and its kinase activity was measured using
myelin basic protein (MBP) as the substrate. Treat-
ment with MTSA-10 resulted in gradual inactivation
of ERK1 ⁄ 2 kinase activity, with maximum inactivation
observed at 45 min after addition of MTSA-10.
Importantly, this inactivation could be reversed with
exogenous ROS supplied in the form of H2O2, which
was found to be comparable with the ERK activity
observed in cells treated with H2O2. This again indica-
ted that reduction in ROS level brought about by
MTSA-10 was playing a key role in ERK1 ⁄ 2 inactiva-
tion (Fig. 6B). Treatment of the cells with an increas-
ing concentration of MTSA-10 led to a corresponding
decrease in ERK kinase activity indicating that
MTSA-10 induced the inactivation of ERK1 ⁄ 2 in a
dose-dependent manner (Fig. 6C). In addition to the
magnitude of enzyme activity, ERK1 ⁄ 2 obtained from
MTSA-10-treated cells also displayed a reduction in
kinetics of substrate phosphorylation (Fig. 6D).
MTSA-10 treatment resulted in a 2.5–3-fold reduction
in the rate of substrate phosphorylation. Thus, MTSA-
10 seemed to directly regulate the proportion of
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ERK1 ⁄ 2 molecules available for activation. This, in
turn, regulated both the extent and the rate of sub-
strate phosphorylation mediated by this kinase.
Cellular signaling has direct implications for tran-
scriptional changes in the nucleus in eukaryotic cells.
The cell-specific gene expression involves a cascade of
controls over transcription factors and the signals that
activate these factors [50]. Mtb is known to reprogram
macrophage transcriptome for its own benefit and to
suppress transcription of a large number of macroph-
age genes considered essential for the host cell activa-
tion [51,52]. A direct repercussion of its impact on
cellular signaling was reflected in the way MTSA-10
was found to modulate the macrophage gene expres-
sion. A selected subset of genes considered essential
for macrophage activation and its primary role as an
antigen-presenting cell, was analyzed by RT-PCR
amplification for their expression in the cells treated
with MTSA-10 (Fig. 7A,B). We found that MTSA-10
downregulated transcription of genes essential for
response to activation molecules such as tumor necro-
sis factor-a and IFN-c, as well as those encoding
costimulatory molecules CD80 and CD86 (Fig. 7A).
This effect was time-dependent, as longer incubation
with MTSA-10 augmented the magnitude of downreg-
ulation.
In view of our other results, we then asked the ques-
tion whether this effect on gene expression was indeed
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Fig. 6. Effect of MTSA-10 on ERK activity. (A) Cells were treated for the indicated time with MTSA-10 alone or in the presence of H2O2 or
sodium orthovanadate (1 mM each). Phosphorylation status of ERK1 ⁄ 2 was examined by western blotting followed by probing with anti-
phospho-ERK sera. (B) ERK1 ⁄ 2 was immunoprecipitated from cells (1 · 107 ⁄ group) treated with MTSA-10 in the absence (d) or presence of
H2O2 (s) and also from cells treated with H2O2 alone (.). These immunoprecipitates were then employed in a kinase assay using MBP as
substrate. Results show the net incorporation of radioactive phosphate in the substrate after background subtraction. (C) Cells were treated
with different concentrations of MTSA-10 for 30 min and ERK was immunoprecipitated from each group and subjected to kinase assay. (D)
ERK was immunoprecipitated from untreated cells (d) and cells stimulated by MTSA-10 (s) for 30 min. The immunoprecipitates obtained
were used in substrate phosphorylation assay where substrate phosphorylation was monitored as a function of time. Values shown repre-
sent the time-dependent increase in MBP phosphorylation. All values were expressed as percent increase in respect to the untreated cells
as control. Whereas (A) is representative of four different experiments, values in (B), (C) and (D) are mean ± SD of three experiments.
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a result of basal signal dampening due to inhibition of
ROS caused by MTSA-10 leading to PTP inactivation.
We therefore treated cells with MTSA-10 after exogen-
ous ROS supplementation in the form of H2O2. The
presence of ROS led to reversal of downregulation of
gene transcription (Fig. 7B). This result indicated that
inhibition of ROS generation, caused by MTSA-10,
not only affected macrophage signaling, but also dis-
abled the macrophage to maintain its basal gene
expression level.
Discussion
The most important observation of the present study
relates to the striking dephosphorylation of macro-
phage proteins by a mycobacterial secretory protein,
MTSA-10, leading to disruption of host cell signaling.
While bacterial pathogens are known to disrupt host-
cell signaling [1], global dampening of macrophage
signaling machinery seen in the presence of MTSA-10
was unexpected. At least within the time frame of our
experiment, MTSA-10-treated macrophages failed to
maintain or recover their basal phosphorylation status.
The dephosphorylation events, which had peaked by
20 min of treatment, were found to be more dominant
both quantitatively and qualitatively than the phos-
phorylation events. This dephosphorylation of cellular
proteins is apparently due to the increased activity of
cellular phosphatases observed as a result of MTSA-10
treatment. It was found that the kinetics of activation
of tyrosine and serine ⁄ threonine phosphatases varies,
and though some reach the basal activation level by
30 min of treatment, others still remain active.
Together they did not allow the treated macrophages
to recover their basal phosphorylation status, even
after 60 min of MTSA-10 treatment.
Another important result we obtained was that
MTSA-10 brought down levels of oxidant species in
macrophages. Importantly, ROS levels dropped rapidly
within seconds of addition of MTSA-10, and this
decline persisted for at least up to 1 h of treatment,
making this effect fairly stable. Furthermore, the inhib-
itory effect of MTSA-10 on macrophage ROS was
dose dependent, indicating a system that could display
a graded shift in its steady state equilibrium. Our
results also showed that the binding of MTSA-10 on
the macrophage surface was necessary to bring about
the changes in ROS levels; the physical presence of
MTSA-10 within the cell had no effect on ROS levels
as observed in the transfected cells. Our unpublished
A B
Fig. 7. MTSA-10 regulates macrophage gene expression by a ROS-dependent mechanism. Profiles of mRNA level of different genes as
obtained by RT-PCR are shown. Cells (1 · 106 ⁄ group) were treated with MTSA-10 for indicated time in (A) and for 6 h in the presence or
absence of H2O2 in (B). Total RNA was isolated from each group and was subjected to RT-PCR with primers specific for the genes indica-
ted. Data shown are representative of three different experiments.
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preliminary observations also suggest that MTSA-10
treatment did not have any appreciable effect on macro-
phage superoxide generation as measured by dihydro-
ethidium oxidation. These results together suggested
that binding of MTSA-10 on the cell surface might be
accelerating the process of breakdown of hydrogen
peroxide to oxygen and water and thereby reducing
the level of available H2O2 in the cell. However, it
needs more work to understand the exact mechanism
of reduction in ROS levels by MTSA-10.
The reduction in ROS levels due to MTSA-10 treat-
ment of cells was the likely cause for increased activity
of the phosphatases and consequent decrease in both
tyrosine and serine ⁄ threonine phosphorylation of the
cellular proteins. As the effect of MTSA-10 on ROS
levels stayed for over an hour, it seemed to facilitate
some of the phosphatases to remain active even after
30 min of MTSA-10 treatment, and to maintain the
dephosphorylated status of the macrophage cellular
proteins over the period of one hour, the time frame
of our experiments. However, a marked exception was
observed in the case of tyrosine phosphatase SHP-1,
which suffered a moderate decrease in its activity fol-
lowing MTSA-10 treatment of the cells. Although the
role of two SHPs both as positive and negative regula-
tors of cellular signaling has been shown [53–55], the
cause of preferential inactivation of SHP-1 in our stud-
ies is presently not clear to us. However, we assume
that there might be a secondary level of regulation in
case of SHP-1, where another not-yet-identified phos-
phatase, activated by MTSA-10, might be inactivating
SHP-1. Further detailed study is necessary to under-
stand the regulatory mechanism of this phosphatase.
In any event, ROS-mediated phosphatase inactivation
has been noted during activation of several receptor
systems, which strongly suggest that inactivation of
phosphatases is sufficient to shift the balance in favor
of signal activation [35,36]. Alternatively, as our pre-
sent results suggest, activation of phosphatases can
shift the balance in favor of signal inactivation.
The dephosphorylation effect of MTSA-10 percola-
ted to downstream signaling molecules, as evident in
the case of ERK phosphorylation at the furthest point
of MAP kinase pathway. It was also evident that this
effect of MTSA-10 could be neutralized by elevation
of ROS levels or inhibition of phosphatases. The ROS
suppression, caused by MTSA-10, attenuated both the
magnitude and kinetics of substrate phosphorylation
by ERK. Because ERK, along with other effector
molecules, carries the signal to the nucleus, we are
inclined to think that it is the effect of ROS on signal
activation that impacts subsequent gene expression. As
our data suggested, it was the effect of MTSA-10 on
ROS generation that compromised macrophage in its
physiological function; while sustained stimulation
with MTSA-10 could lead to further downregulation
of the activation markers and early response genes,
external supply of ROS fully overcame this effect. This
indicates that the inhibition of ROS generation by
MTSA-10 was the ‘control switch’ that tuned the con-
sequent downstream effects.
Not being equipped to produce OxyR, a critical con-
stituent of the oxidative stress response as in other intra-
cellular bacteria like Escherichia coli and Salmonella
typhimurium,Mtb seems to have armed itself with a host
of components to deal with ROS or oxidative stress,
such as a catalase peroxidase, KatG [56,57], and two
superoxide dismutase proteins, SodA and SodC [58,59].
Our present study indicates that a secretory protein like
MTSA-10 can also downregulate ROS generation in the
cultured macrophages. More work will be required
to establish relevance of these observations in the
Mtb–macrophage interaction, using Mtb mutants.
MTSA-10 has been reported to exist predominantly
as part of the 1 : 1 complex of MTSA-10 and ESAT-6
[27,60]. Conversely, Gao et al. [61] have provided evi-
dence for discordance between secretion of ESAT-6
and MTSA-10; their findings indicated that complexa-
tion between these two molecules was not required for
secretion of MTSA-10. It is evident from the present
study that the binding of MTSA-10 alone to the cell
surface exerted an inhibitory effect on the macrophage
ROS generation that was similar to the one obtained
with the MTSA-10–ESAT-6 complex (Fig. S3A,D).
Our findings suggest that it is MTSA-10 in the com-
plex that plays the role of modulator of immune func-
tion. The study of regulation of macrophage signaling
by MTSA-10 can thus extend our knowledge, at least
to some extent, as to how the MTSA-10–ESAT-6 com-
plex might regulate the macrophage functions. Interest-
ingly, a recent study has found that human T-cell
responses to the MTSA-10–ESAT-6 complex were
inferior to those induced with ESAT-6, and that these
were only as good as those achieved with MTSA-10
alone [62]. Furthermore, MTSA-10 was responsible for
preventing digestion of the MTSA-10–ESAT-6 com-
plex with lysosomal enzymes (cathepsins L and S), sug-
gesting inhibitory ⁄ regulatory role of MTSA-10 in the
antigen processing [62]. It may be pertinent to point
out that Okkels et al. [63] have reported presence of as
many as eight species of ESAT-6 in Mtb short-term
culture filtrate; three of these were acetylated
and showed preferential binding of MTSA-10. This
observation also raises the possibility that at least
some proportion of MTSA-10 and ESAT-6 may,
indeed, exist as independent moieties, potentially
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capable of exerting their individual influence on the
host cell responses.
In conclusion, this study presents evidence for the
ability of a Mtb secretory protein, MTSA-10, to modu-
late cell signaling by activating phosphatases through
downregulation of innate ROS levels in the cultured
host cell. However, a number of questions remain to be
addressed; for example, a detailed characterization of
this novel interaction between MTSA-10 and the host
cell must be carried out with deletion mutants of Mtb
in primary macrophage cultures. Furthermore, a study
on possible impact of immune effector molecules like
IFN-c and tumor necrosis factor-a on the MTSA-10–
macrophage interaction will be required to gain a better
perspective on this interaction.
Experimental procedures
Cell lines and reagents
A mouse tumor-derived macrophage-monocyte cell line
J774A.1 and a murine macrophage-like cell line RAW264.7,
originally obtained from the American Type Culture Collec-
tion (ATCC; Manassas, VA, USA), were procured from the
National Centre for Cell Science (Pune, Maharashtra, India),
and maintained in DMEM (Life Technologies, Carlsbad,
CA, USA) supplemented with 10% heat-inactivated fetal
bovine serum (Life Technologies), at 37 C in 5% CO2.
Affinity-purified, LPS-free, recombinant 6xHis-tagged
MTSA-10 protein, cloned in bacterial expression vector
pQE-31 (Qiagen, Valencia, CA, USA), was prepared as des-
cribed [26]. Recombinant ESAT-6 and Ag85B proteins of
Mtb were also expressed and purified in-house following
standard procedures ([65]; A. Grover and P. Sharma, unpub-
lished data). Purified recombinant 19-kDa fragment of
P. falciparum merozoite surface protein-1 (PfMSP-119),
cloned in pQE vector system, was a kind gift from P. Malho-
tra (Malaria Research Group, ICGEB, New Delhi, India).
QIAexpressionist protein expression and purification kit
including Ni-NTA-Agarose, gel purification kit and all
primers used for amplification of c-DNA were from Qiagen.
Protein A-agarose, 5-bromo-4-chloro-3-indolyl-beta-d-gal-
actopyranoside (X-gal), isopropyl-thio-d-galactopyranoside,
ampicillin, kanamycin, pNPP, DPI, NAC, Ebselen, l-NG-
monomethyl arginine (l-NMMA), dephosphorylated casein,
MBP, sodium orthovanadate (Na3VO4), sodium fluoride,
aprotinin, pepstatin, leupeptin, iodoacetamide were pur-
chased from Sigma (St Louis, MO, USA). Bacto tryptone,
yeast extract and Bacto agar were from Difco (San Diego,
CA, USA). Immobilized pH gradient (IPG) dry-strips,
dithiothreitol and other chemicals used for two-dimensional
gel electrophoresis were from Amersham Biosciences (Upp-
sala, Sweden). H2DCFDA and dihydroethidium were from
Molecular Probes (Eugene, OR, USA). IL-12p40 detection
ELISA kit was from BD Pharmingen (San Diego, CA,
USA). The serine ⁄ threonine phosphatase assay kit was from
Upstate (Charlottesville, VA, USA). All the antibodies used
for immunoprecipitation, western blotting, and the enhanced
chemiluminescence kit were from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). [32P]-Orthophosphoric acid was
from Perkin-Elmer (Boston, MA, USA).
Treatment of cells with MTSA-10 and the
resolution of phosphorylated proteins by
two-dimensional gel electrophoresis
J774A.1 cells (1 · 107) were placed in phosphate-free
DMEM supplemented with 1% fetal bovine serum for 2 h
before [32P]-orthophosphoric acid (0.5 mCiÆmL)1) was
added and the incubation continued for an additional 4–
5 h. One set of these cultures was then treated with affinity
purified, LPS-free, recombinant MTSA-10 protein at a final
concentration of 10 lgÆmL)1 for indicated time while
another set received no such treatment and served as con-
trol. The cytoplasmic fractions of cell lysates were prepared
and resolved by two-dimensional gel electrophoresis, which
was performed essentially as described elsewhere [64], using
IPG strips (Amersham Biosciences). Briefly, J774.1 cells
from the MTSA-10- or mock-treated cultures were harves-
ted and washed once with culture medium by centrifuga-
tion, disrupted in the lysis buffer (8 m urea, 4% Chaps and
2% (v ⁄ v) IPG buffer pI 4–7), and their cytoplasmic frac-
tions obtained by ultracentrifugation. The cell extracts
corresponding to different time points were diluted in
rehydration buffer (8 m urea, 2% (v ⁄ v) Chaps, 0.28%
(w ⁄ v) dithiothreitol, 0.5% (v ⁄ v) IPG buffer pI 4–7), and
applied to IPG strips, pI 4–7, using the ‘in-gel rehydration’
method. The isoelectrofocusing was performed in the IPG-
phor isoelectrofocusing system (Amersham Biosciences),
with the following voltage program: gradient from 0 to
500 V in 2 h, 500 V constant for 5 h, gradient from 500 to
4000 V in 2 h, step up to 4500 V and hold for 1 h, and
finally step up to 5000 V constant until 22–24 kVh. Later,
IPG strips were equilibrated in solutions A (50 mm
Tris ⁄HCl, pH 8.8 containing 6 m urea, 30% glycerol, 2%
SDS, 1% dithiothreitol) and B (solution A without dithio-
threitol, but with 2.5% iodoacetamaide and 0.005% bromo-
phenol blue). Each strip was then loaded on to top of a
SDS ⁄PAGE slab (12% gel, 1-mm thick) and electrophoresis
was performed at a constant current of 20mA per gel, to
resolve the focused proteins in the second dimension.
The resultant gels were silver stained to ascertain that
comparable quantities of proteins from experimental and
control groups were loaded for analysis. Dried gels were
then exposed to X-ray films. Phosphoproteins were visual-
ized by autoradiography and digitized on a Molecular
Dynamics computing densitometer using image quant
software, version 5.2, and were analyzed using image
master 2d software version 4.01 (Amersham Biosciences).
S. K. Basu et al. Modulation of macrophage function by MTSA-10
FEBS Journal 273 (2006) 5517–5534 ª 2006 The Authors Journal compilation ª 2006 FEBS 5529
Only spots with an area greater than 75 pixels were consid-
ered, and the minimum intensity surrounding the spot on
the film was taken as its background and subtracted to give
the true intensity. Relative quantification was achieved by
normalizing against three distinct spots that were unaffec-
ted upon stimulation of cells. Calibration for the molecular
mass and pI was carried out on the basis of standard mark-
ers that were run on parallel gels.
Cellular fractionation and phosphatase assay
Following incubation of J774.1 cells with MTSA-10 for indi-
cated time, for assessment of tyrosine phosphatases, cells
were lysed for 20 min at 4 C in lysis buffer (10 mm Hepes,
pH 7.4, 10% glycerol and 10 lgÆmL)1 each of aprotinin and
pepstatin). The phosphatase assay was done using pNPP as
substrate as described earlier [66]. Briefly, 20 lg of total pro-
tein fraction or the immunoprecipitates were incubated in
assay buffer (5 mm Mes, pH 6.4, 1 mm EDTA pH 8.0,
0.1% Triton X-100) with 100 lg pNPP per reaction at 37 C
for the required time. The reaction was stopped by adding
2 m NaOH, and the absorbance was measured at 405 nm.
For serine ⁄ threonine phosphatases, the cells were lysed
for 20 min at 4 C in lysis buffer (15 mm Hepes pH 7.4,
150 mm NaCl, 1 mm EGTA, 0.1 mm MgCl2 and 1% Triton
X-100 with 10 lgÆmL)1 each of aprotinin and pepstatin).
The assay was carried out using Upstate Ser ⁄Thr phospha-
tase assay kit according to the instructions provided by
manufacturer in the kit protocol.
The individual phosphatases were immunoprecipitated
from the respective cytoplasmic fractions by incubating
with 1 lg of respective antibody for 2 h at 4 C, followed
by the addition of 40 lL of protein A-Sepharose for
another 2 h. The resultant immunoprecipitates were assayed
for phosphatase activity using respective assay protocol.
Isolation of RNA and RT-PCR
RNA was isolated from the treated cells (1 · 106) at indica-
ted time points using Trizol reagent according to manufac-
turer’s recommendations. Two microgram of RNA from
each group was subjected to reverse transcription using oli-
go(dT)20 and Superscript II Reverse Transcriptase (Invitro-
gen). The cDNAs were amplified by PCR with appropriate
primers. The sequence of primers used for PCR amplifica-
tion of different genes is given in supplementary Table S1.
ERK kinase assay
For kinase assay, ERK 1 ⁄ 2 was immunoprecipitated from
J774.1 cells (1 · 107 ⁄ time point ⁄ treatment). The immuno-
precipitates were washed and then incubated in the kinase
reaction buffer [20 mm Tris (pH 7.5), 20 mm MgCl2, 2 mm
dithiothreitol, 10 lm unlabelled ATP and 10 lCiÆtube)1
of [32P]-ATP]. The reaction was initiated by addition of
5 lgÆtube)1 of MBP at 30 C for 10 min or as mentioned.
The reaction was terminated by addition of 6· SDS loading
buffer followed by boiling for 5 min. The reaction mixtures
were subjected to SDS ⁄PAGE. Comparable amounts of
ERK1 ⁄ 2 in different groups were ensured by silver staining
of the resultant gels. Dried gels were then exposed to X-ray
films and amount of [32P]-ATP incorporation in the sub-
strate was ascertained by autoradiography followed by den-
sitometric analysis.
Measurement of reactive oxygen species
Spectrofluorimetry
For spectrofluorimetry, J774A.1 cells (5 · 106 cells in each
case) were suspended in 1 mL of serum-free DMEM and
labeled with 1 lm of H2DCFDA for 15 min at 37 C. Cells
were washed twice with medium and re-suspended in
750 lL of medium. The suspension (100 lL) was pipetted
into each well of the 96-well plate supplied by the manufac-
turer. Stimulants were pumped into the wells at the desired
time points. The fluorescence was measured by Floustar
Optima spectrofluorimeter of BMG laboratories (Offen-
burg, Germany), using filters that allowed absorption spec-
trum of 480 nm and emission spectrum of 520 nm.
Flowcytometry
For flowcytometry, the cells (5 · 106 cells in each case)
were suspended in 1 mL of medium and labeled with 1 lm
of H2DCFDA for 15 min at 37 C. Cells were washed twice
with medium and resuspended in 1 mL of medium. Treat-
ment was done as applicable and cells were used for FACS
analysis at 5- and 10-min time intervals.
Isolation of mouse peritoneal macrophages
Mouse peritoneal macrophages were obtained from resident
peritoneal cells of BALB ⁄ c mice. The animals were anesthe-
tized and the resident peritoneal cells were harvested,
pooled and counted with a hemocytometer. This cell sus-
pension was adjusted to 1 · 106 viable cells per mL in
DMEM and incubated for 2 h at 37 C. The adherent cells
were collected and used for further experiments. Experi-
mental procedures requiring animal use were as per the
guidelines set out by the Institute for Laboratory Animal
Research (Washington DC) [67] and approved by the Insti-
tutional Animal Ethics Committee.
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Supplementary material
The following supplementary material is available
online:
Fig. S1. MTSA-10 induced dephosphorylation is a glo-
bal phenomenon. The figure shows a diagrammatic
illustration of relative change in phosphorylation levels
of the individual spots seen in Fig. 1(A). Left end
of the line represents the relative phosphorylation
level of an individual spot in untreated cells while right
end of the line represents the relative phosphorylation
level of that spot in MTSA-10-treated cells. An arbi-
trary scale is used that reflects the relative levels of
phosphorylation of each spot. All values represent
average of values obtained in three different experi-
ments.
Fig. S2. Effect of MTSA-10 on macrophage ROS gen-
eration is a stable phenomenon. (A–F) show the FACS
profiles of ROS generation in macrophage as measured
by H2DCFDA oxidation in untreated cells (——) and
MTSA-10-treated cells (-----). The cells were treated
with MTSA-10 for 20 min (A), 40 min (B), 1 h (C), 3
h (D), 6 h (E) and 9 h (F).
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Fig. S3. Effect of macrophage ROS generation is
MTSA-10 specific. A–D show the FACS profiles of
ROS generation as measured by H2DCFDA oxidation.
All treatments were carried out for 10 min. (A) shows
ROS FACS profile in untreated J774.1 cells (——),
and MTSA-10-treated cells (-----); (B), ROS profiles
obtained for untreated cells (——), and ESAT-6
(10 lgÆmL)1)-treated cells (-----); (C), the ROS profiles
for untreated cells (solid line), or cells treated simulta-
neously with MTSA-10 and ESAT-6 (-----), and (D)
shows the ROS profiles of untreated cells (——) and
MTSA-10–ESAT-6 (1 : 1) complex (10 lgÆmL)1) trea-
ted cells (-----). All the figures are representative of
three different experiments.
Fig. S4. Regulation of ROS by MTSA-10 is a general
phenomenon. The FACS profiles of ROS generation
by H2DCFDA labeled macrophage cells are shown. In
(A), FACS profiles of DCFDA labeled untreated
RAW 264.7 cells (——) and cells treated with MTSA-
10 (-----) are shown. In (B), the profiles of J774.1 cells
pretreated with l-N-monomethyl arginine (——), and
those treated with MTSA-10 (-----) are shown. Data
are representative of four experiments.
Fig. S5. MTSA-10 exerts similar effects on primary
macrophages. (A–D) show FACS profiles of ROS
generation by mouse peritoneal macrophages. All the
treatments shown are for 10 min. In (A), profiles
for the untreated (——) and MTSA-10 treated (-----)
cells are shown; in (B), the ROS profiles for untreated
(——) and ESAT-6 (10 lgÆmL)1) treated (-----) cells
are shown; in (C), for the untreated (——) and cells
treated simultaneously with both MTSA-10 and
ESAT-6 (-----) are shown; and in (D), the profile for
untreated cells (——) is shown along with that for
MTSA-10–ESAT-6 (1 : 1) complex (10 lgÆmL)1)-trea-
ted cells. (E) shows the phosphorylation profile of
ERK in mouse peritoneal macrophage treated with
MTSA-10 for indicated time. The cell lysates repre-
senting different treatment times were subjected to
western blotting followed by probing with phospho-
ERK-specific antibodies. The blots were stripped and
reprobed with antibodies against ERK molecule. All
the data are representative of three to four different
experiments.
Table S1. Nucleotide sequence of the primers used in
RT-PCR.
This material is available as part of the online article
from http://www.blackwell-synergy.com
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